Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 20, 2009, Pages 1209-1216

  Sacco, Sandra M ^a   Jiang, Jessica M Y ^a   Reza López, Sandra ^a   Ma, David W L ^b   Thompson, Lilian U ^a   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LINSEED OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRENGTH; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FEMUR; LINSEED; LIPID COMPOSITION; LOW DRUG DOSE; LUMBAR VERTEBRA; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TIBIA; ULTRA LOW DRUG DOSE;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; ESTROGENS; FEMALE; FEMUR; FLAX; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

RATTUS;

EID: 75149125561     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903127121     Document Type: Article

References (33)

1. Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., Johnson, K. C., Judd, H., Kotchen, J. M., Kuller, L., LaCroix, A. Z., Lane, D., Langer, R. D., Lasser, N., Lewis, C. E., Manson, J., Margolis, K., Ockene, J., O'Sullivan, M. J., Phillips, L., Prentice, R. L., Ritenbaugh, C., Robbins, J., Rossouw, J. E., Sarto, G., Stefanick, M. L., Van Horn, L., Wactawski-Wende, J., Wallace, R., Wassertheil-Smoller, S., Women's Health Initiative Steering Committee. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 291:1701-1712. (Pubitemid 38489892)
2. Breitman, P. L., Fonseca, D., and Ward, W. E. 2005. Combination of soy protein and high dietary calcium on bone biomechanics and bone mineral density in ovariectomized rats. Menopause 12:428-435.
3. Breitman, P. L., Fonseca, D., Cheung, A. M. and Ward, W. E. 2003. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 33:597-605.
4. Brooks, J. D., Ward, W. E., Lewis, J. E., Hilditch, J., Nickell, L., Wong, E., and Thompson, L. U. 2004. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am. J. Clin. Nutr. 79:318-325.
5. Canadian Council on Animal Care. 1993. Guide to the care and use of experimental animals. Ottawa: Canadian Council on Animal Care.
6. Ettinger, B., Ensrud, K. E., Wallace, R., Johnson, K. C., Cummings, S. R., Yankov, V., Vittinghoff, E., and Grady, D. 2004. Effects of ultralow-dose transdermal estradiol on bone mineral density: A randomized clinical trial. Obstet. Gynecol. 104:443-451.
7. Feng, J., Shi, Z., and Ye, Z. 2008. Effects of metabolites of the lignans enterolactone and enterodiol on osteoblastic differentiation of MG-63 cells. Biol. Pharm. Bull. 31:1067-1070.
8. Folch, J., Lees, M., and Sloane Stanley, G. H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:497-509.
9. Fonseca D., and Ward, W. E. 2004. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35:489-497.
10. Gambacciani, M., Cappagli, B., Ciaponi, M., Pepe, A., Vacca, F., and Genazzani, A. R. 2008. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas 59:2-6.
11. Grady, D. 2006. Clinical practice. Management of menopausal symptoms. N. Engl. J. Med. 355:2338-2347.
12. Griel, A. E., Kris-Etherton, P. M., Hilpert, K. F., Zhao, G., West, S. G., and Corwin, R. L. 2007. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr. J. 6:1-8.
13. Jiang, J. M., Sacco, S. M., and Ward, W. E. 2008. Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats. J. Nutr. 138:2106-2110.
14. Kim, M. K., Chung, B. C., Yu, V. Y., Nam, J. H., Lee, H. C., Huh, K. B., and Lim, S. K. 2002. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin. Endocrinol. (Oxf.) 56:321-328.
15. Lindsay, R., Gallagher, J. C., Kleerekoper, M., and Pickar, J. H. 2002. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. J. Am. Med. Assoc. 287:2668-2676.
16. Mahady, G. B., Parrot, J., Lee, C., Yun, G. S., and Dan, A. 2003. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 10:65-72.
17. McElroy, J. F., and Wade, G. N. 1987. Short-and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats. Physiol. Behav. 39:361-365.
18. Mollard, R. C., Gillam, M. E., Wood, T. M., Taylor, C. G., and Weiler, H. A. 2005. (n-3) Fatty acids reduce the release of prostaglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J. Nutr. 135:499-504.
19. Morgan, E. F., Barnes, G. L. and Einhorn, T. A. Marcus, R., Feldman, D., Nelson, D., and Rosen, C. J., ed. 2008. The bone organ system: form and function. In Osteoporosis, pp. 3-26. Burlington, MA: Elsevier Academic Press.
20. Nesbitt P. D., Lam, Y., and Thompson, L. U. 1999. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am. J. Clin. Nutr. 69:549-555.
21. Penttinen, P., Jaehrling, J., Damdimopoulos, A. E., Inzunza, J., Lemmen, J. G., van der Saag, P., Pettersson, K., Gauglitz, G., Mäkelä, S., and Pongratz, I. 2007. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148:4875-4886.
22. Plourde, M., and Cunnane, S. C. 2007. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 32:619-634.
23. Power, K. A., Thompson, L. U., Awad, A. B., and Bradford, P. G., ed. 2006. Flaxseed and lignans: Effects on breast cancer. In Nutrition and cancer prevention, pp. 385-410. Boca Raton, FL: CRC Press.
24. Prestwood K. M., Kenny, A. M., Kleppinger, A., and Kulldorff, M. 2003. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: A randomized controlled trial. J. Am. Med. Assoc. 290:1042-1048.
25. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939-1951.
26. Reinwald, S., Li, Y., Moriguchi, T., Salem, N., Jr., and Watkins, B. A. 2004. Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats. J. Nutr. 134:388-394.
27. Richman, S., Edusa, V., Fadiel, A., and Naftolin, F. 2006. Low-dose estrogen therapy for prevention of osteoporosis: Working our way back to monotherapy. Menopause 13:148-155.
28. Roy, E. J., and Wade, G. N. 1977. Role of food intake in estradiol-induced body weight changes in female rats. Horm. Behav. 8:265-274.
29. Sacco, S. M., Jiang, J. M., Reza-López, S., Ma, D. W., Thompson, L. U., and Ward, W. E. 2009. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause 16:545-554.
30. Sakaguchi, K., Morita, I., and Murota, S. 1994. Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukotrienes Essential Fatty Acids 50:81-84.
31. Singh, S. R., and Levine, M. A. 2006. Natural health product use in Canada: Analysis of the National Population Health Survey. Can. J. Clin. Pharmacol. 13:e240-e250.
32. Thompson, L. U., Robb, P., Serraino, M., and Cheung, F. 1991. Mammalian lignan production from various foods. Nutr. Cancer 16:43-52.
33. Watkins, B. A., Li, Y., and Seifert, M. F. 2006. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J. Nutr. Biochem. 17:282-289.